Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS i and ARTS II

EuroIntervention

Volumn 4, Issue 4, 2009, Pages 492-501

  Vaina, Sophia ^a   Voudris, Vassilis ^b   Morice, Marie Claude ^c   De Bruyne, Bernard ^d   Colombo, Antonio ^e   MacAya, Carlos ^f   Richardt, Gert ^g   Fajadet, Jean ^h   Hamm, Christian ⁱ   Schuijer, Monique ^j   MacOurs, Nathalie ^k   Stoll, Hans Peter ^k   Cokkinos, Dennis V ^b   Stefanadis, Christodoulos ^a   Serruys, Patrick W ^l  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^d OLV HOSPITAL   (Belgium)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g Segeberger Kliniken GmbH   (Germany)

^h CLINIQUE PASTEUR   (France)

ⁱ KERCKHOFF HEART CENTER   (Germany)

^j CARDIALYSIS   (Netherlands)

^k Cordis Clinical Research EMAE ^*  (Belgium)

^l ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Angioplasty; Bare metal stent; Sirolimus eluting stent

Indexed keywords

CARDIOVASCULAR AGENT; METAL; RAPAMYCIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EUROPE; FEMALE; HUMAN; INSTRUMENTATION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSTHESIS; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RISK ASSESSMENT; SEX DIFFERENCE; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; WOMEN'S HEALTH;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; EUROPE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; PROSTHESIS DESIGN; REOPERATION; RISK ASSESSMENT; SEX FACTORS; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 63049106940     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV4I4A84     Document Type: Article

References (29)

1. Kitler ME. Coronary disease: are there gender differences? Eur Heart J. 1994;15: 409-417.
2. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335: 217-225.
3. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360: 965-970.
4. King SB 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35: 1116-1121.
5. Unger F, Serruys PW, Yacoub MH, Ilsley C, Paulsen PK, Nielsen TT, Eysmann L, Kiemeneij F. Revascularization in multivessel disease: comparison between two-year outcomes of coronary bypass surgery and stenting. J Thorac Cardiovasc Surg. 2003;125: 809-820.
6. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation. 1993;87: 720-727.
7. Argulian E, Patel AD, Abramson JL, Kulkarni A, Champney K, Palmer S, Weintraub W, Wenger NK, Vaccarino V. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol. 2006;98: 48-53.
8. Chauhan MS, Ho KK, Baim DS, Kuntz RE, Cutlip DE. Effect of gender on in-hospital and one-year outcomes after contemporary coronary artery stenting. Am J Cardiol. 2005;95: 101-104.
9. Malenka DJ, Wennberg DE, Quinton HA, O'Rourke DJ, McGrath PD, Shubrooks SJ, O'Connor GT, Ryan TJ, Robb JF, Kellett MA, Bradley WA, Hearne MA, VerLee PN, Watkins MW, Hettleman BD, Piper WD. Genderrelated changes in the practice and outcomes of percutaneous coronary interventions in Northern New England from 1994 to 1999. J Am Coll Cardiol. 2002;40: 2092-2101.
10. Aldea GS, Gaudiani JM, Shapira OM, Jacobs AK, Weinberg J, Cupples AL, Lazar HL, Shemin RJ. Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting. Ann Thorac Surg. 1999;67: 1097-1103.
11. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344: 1117-1124.
12. Voudris V, Ong A, Serruys P, Sianos G, Stavrides G, Lindeboom W, Cokkinos DV, on behalf of the Arterial Revascularisation Therapy Study (ARTS) Investigators. Sex differences and their impact on clinical outcome after percutaneous or surgical revascularisation: a report from the Arterial Revascularisation Therapies Study (ARTS). EuroInterv. 2006;2: 175-180.
13. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346: 1773-1780.
14. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. Oneyear clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004;109: 1942-1947.
15. Serruys P, Ong A, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, O'Malley JA, Bressers M, Donohoe D, on behalf od the ARTS II Investigators. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroInterv. 2005;1: 147-156.
16. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115: 2344-2351.
17. O'Connor GT, Morton JR, Diehl MJ, Olmstead EM, Coffin LH, Levy DG, Maloney CT, Plume SK, Nugent W, Malenka DJ. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. Circulation. 1993;88: 2104-2110.
18. Thompson CA, Kaplan AV, Friedman BJ, Jayne JE, Gerling BR, Niles NW, Hettleman BD, Robb JF. Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era. Catheter Cardiovasc Interv. 2006;67: 25-31.
19. Weintraub WS, Wenger NK, Jones EL, Craver JM, Guyton RA. Changing clinical characteristics of coronary surgery patients. Differences between men and women. Circulation. 1993;88:II79-86.
20. Weintraub WS, Wenger NK, Kosinski AS, Douglas JS, Jr., Liberman HA, Morris DC, King SB 3rd. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol. 1994;24: 81-90.
21. Mikhail GW. Coronary revascularisation in women. Heart. 2006;92 Suppl 3:iii19-23.
22. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schuhlen H, Dirschinger J, Schomig A. Gender and restenosis after coronary artery stenting. Eur Heart J. 2003;24: 1523-1530.
23. Jacobs AK, Kelsey SF, Yeh W, Holmes DR, Jr., Block PC, Cowley MJ, Bourassa MG, Williams DO, King SB, 3rd, Faxon DP, Myler R, Detre KM. Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. Am J Cardiol. 1997;80: 979-984.
24. Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, Schomig A. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. Jama. 2000;284: 1799-1805.
25. Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol. 2005;45: 1180-1185.
26. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349: 1315-1323.
27. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB, 3rd, Hamm CW, Puel J, Hueb W, Goy JJ, Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346: 1184-1189.
28. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41: 1293-1304.
29. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369: 667-678.